During the medical rescue after Wenchuan earthquake, the Department of Appliances and Materials of West China Hospital took prompt action to ensure the regular operation of hospital devices and facilities. Meanwhile, owing to its specialized superiority of material and appliance purchase as well as the optimized processes for material and appliance supply, the hospital ensured the effective supply of disaster relief materials and efficiently managed the consumption of donated materials. From May 12 to 30, a total of 2 200 000 pieces of medical materials (total value RMB 3 770 000 Yuan) and 220 sets of medical appliance (total value RMB 9 000 000 Yuan) were purchased as part of the immediate medical rescue response to the earthquake.
Theory of risk control was introduced to medical instruments quality control management in West China Hospital. A quality control system for the whole life cycle management of instruments has been established, which includes evaluation before instrument purchase, policy and management of bidding, operation training, safe maintenance, maintenance management and waste disposal. Medical instrument quality system was introduced to provide information for medical instrument risk control and quality management in a large, general Chinese hospital.
目的 评价选择性介入治疗在原发性肝癌(HCC)门脉高压症中的应用价值。 方法 2008年11月-2011年3月,收治65例临床明确诊断的HCC伴门脉高压症患者,选择性使用肝动脉化学疗法(化疗)栓塞术、脾栓塞术、门静脉化疗栓塞术、门静脉支架、胃冠状静脉栓塞术等介入术式,术后通过观察临床指标、定期复查影像检查等了解病变转归,随访生存期并评价疗效。 结果 65例HCC患者均合并不同程度门静脉高压,其中门静脉癌栓46例中有37例显示肝动脉-门静脉分流,通过肝动脉及门静脉化疗栓塞术进行主瘤体及癌栓治疗。11例行门静脉支架置入术,支架置入后门静脉压较术前明显下降(P<0.01),支架中位通畅时间为5.8个月。39例行胃冠状静脉和(或)胃短静脉栓塞术,术后有4例再次发生门脉高压性出血,再出血率10.26%。18例行脾动脉栓塞术,术后3个月血小板较术前显著升高(P<0.01)。随访术后3、6、12及24个月的生存率分别为90.77%、69.23%、35.38%及13.85%。 结论 选择性联合使用各种介入术式是治疗HCC及其相关性门脉高压症的一种有效方法,可有效预防高危风险,延长患者生存期。